| Literature DB >> 24880889 |
Nicholas Ah Mew1, Robert McCarter2, Yevgeny Daikhin3, Uta Lichter-Konecki1, Ilana Nissim3, Marc Yudkoff3, Mendel Tuchman4.
Abstract
Identical studies using stable isotopes were performed before and after a 3-day trial of oral N-carbamyl-l-glutamate (NCG) in 5 subjects with late-onset carbamyl phosphate synthetase deficiency. NCG augmented ureagenesis and decreased plasma ammonia in 4 of 5 subjects. There was marked improvement in nitrogen metabolism with long-term NCG administration in 1 subject.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24880889 PMCID: PMC4111993 DOI: 10.1016/j.jpeds.2014.04.012
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406